Stanford University ( Site 0023) is a clinical research site located in Stanford, California, United States 94305.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Stanford University ( Site 0023) has participated in 1 clinical trials.
Therapeutic areas: Bladder Cancer.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford University ( Site 0023) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford University ( Site 0023) has 1 clinical trials on record. Their work covers Bladder Cancer.
Stanford University ( Site 0023) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.